Our Projects

Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.

Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.

 

 

Filters / Search

Grant focus
Prevent HIV transmission to people at high risk of infection in three Latin American countries.

Grantees
Foundation for Scientific and Technological Development in Health (Fiotec)

Status
Current

Amount
US$ 26,355,192

Disease
HIV and Co-Infection

Preventing HIV infections in high-risk groups

View More

Grant focus
Expanding knowledge to make lifesaving medicines affordable

Grantees
Third World Network

Status
Current

Amount
US$ 4,899,620

Disease
Cross-cutting

Building country capacity to make lifesaving medicines affordable

View More

Grant focus
Collect data to determine whether a large-scale introduction of a malaria vaccine in Africa is workable.

Grantees
World Health Organization

Status
Current

Amount
US$ 9,600,000

Disease
Malaria

Piloting the world’s first malaria vaccine

View More

Grant focus
Improve prevention, diagnosis and treatment of HIV/AIDS, hepatitis C, tuberculosis and malaria through quality-assurance of health products.

Grantees
World Health Organization

Status
Current

Amount
US$ 157,000,000

Disease
HIV and Co-Infection, Malaria, Tuberculosis

Support for WHO prequalification of diagnostics and medicines

View More

Grant focus
Provide pregnant women with intermittent doses of sulfadoxine-pyramethamine, a medicine that prevents malaria, and gather data on delivery through community health workers.

Grantees
Jhpiego

Status
Current

Amount
US$ 49,653,329

Disease
Malaria

Preventive malaria medicine to protect pregnant women and their babies

View More

Ajara waits at the ART clinic. She is coinfected with HIV and TB. Image: John Rae / The Global Fund

Grant focus
Enable the scale-up of optimized second-line combination antiretroviral therapy for HIV patients who have failed first-line therapy

Grantees
University of New South Wales (Kirby Institute)

Status
Current

Amount
US$ 8,806,936

Disease
HIV and Co-Infection

Comparing a dolutegravir + darunavir combination to the standard treatment for HIV patients who have failed first-line therapy

View More

Grant focus
Reduce rates of mother-to-child transmission of HIV among women starting antiretroviral treatment in the third trimester of pregnancy

Grantees
University of Liverpool

Status
Current

Amount
US$ 8,884,929

Disease
HIV and Co-Infection

Dolutegravir in pregnant mothers and newborns

View More

Grant focus
Improve antiretroviral treatment for HIV-positive people in low- and middle-income countries

Grantees
Wits Reproductive Health & HIV Institute

Status
Current

Amount
US$ 12,929,422

Disease
HIV and Co-Infection

Safer, more robust and less expensive first-line antiretroviral therapy

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.